メタボロミクスの進展

Abstract

This research service analyzes the global trends in the metabolomics with a focus on the current and prospective applications of this platform.

Table of Contents

1 EXECUTIVE SUMMARY

• Scope and Methodology
  • Scope and Segmentation of the Research Service
  • Research Methodology
• Overview of Metabolomics
  • The Road to Metabolomics
  • Technology Platform for Metabolomics
  • Applications of Metabolomics

2 ASSESSMENT OF ENABLING TECHNOLOGIES--METABOLOMICS

• Noteworthy Innovations in Companies and Universities
  • Tracer-Based Metabolomics Platform
  • Biospectroscopy-Based Metabolomics
  • Chenomx NMR Suite for Analysis of NMR spectra
  • Pathway Studio Software for Data Analysis
  • Metabolomics--Technology Improvements
  • Software Implemented to Manage Data in Metabolomics Studies
  • Integrated Metabolomics Platform Aids in Biomarker Discovery
  • Mass Spectrometry for Omics Studies
  • The KnowItAll Informatics System for Metabolic Studies
  • AutoNano System for Mass Spectrometry Analysis
  • NMR Chip for Remote Detection of NMR
• Drivers and Challenges
  • Drivers
  • Challenges

3 ASSESSMENT OF METABOLOMICS APPLICATIONS

• Noteworthy Innovations in Companies and Universities
  • Researchers Hone in on Metabolites to Predict Drug Efficiency
  • Metabolomic Biomarker Discovery Platform
  • Highly Integrated State-of-the-Art NMR Spectrometer for Academic and Industry Applications
  • Metabolic Profiling to Determine Human Embryo Viability
  • Stem Cells and Metabolomics--New Avenues in Biomarker Discovery
  • Application-Oriented Version of HPLC
  • Oxidative Stress Markers in Cardiovascular Diseases
• Drivers and Challenges
  • Drivers
  • Challenges

4 STRATEGIC EVALUATION OF THE COMPETITIVE ENVIRONMENT

• AHP--Prioritization of Metabolomics Technologies--Criteria
  • Definition of Criteria
  • Snapshot of Assessment Criteria Used for Evaluation
• AHP--Prioritization of Metabolomics Technologies--Computation and Analyst Insights
  • AHP Process and Computation for Goal Node and Level 0 Criteria
  • AHP Process and Computation for Goal Node and Level 1 Criteria
  • Final Priorities and Analyst Insights

5 PATENTS AND DATABASE OF KEY INDUSTRY PARTICIPANTS

• Patents
  • Industry Patents
  • Academic Patents
• Key Participants
  • Companies
  • Universities

6 DECISION SUPPORT DATABASE

• Database Tables
  • Global R&D Investment for Biotechnology (2002 to 2012)
  • Percent Government R&D Investment in Biotechnology (2002 to 2012)
  • Global Pharmaceutical R&D Expenditure (2002 to 2012)
  • Global Percentage Pharmaceutical R&D Expenditure (2002 to 2012)